Literature DB >> 12472587

Two double heterozygous mutations in the F7 gene show different manifestations.

Keiko Nagaizumi1, Hiroshi Inaba, Takashi Suzuki, Yoshihiro Hatta, Takeshi Hagiwara, Kagehiro Amano, Morio Arai, Katsuyuki Fukutake.   

Abstract

We sequenced the factor VII gene (F7) in two unrelated Japanese patients with factor VII (FVII) deficiency. In the first (an asymptomatic 46-year-old man with FVII activity and antigen levels of 1.2% and 21% of normal respectively), novel E25K and H348Q mutations were identified in the doubly heterozygous state. In transiently transfected HEK293 cells, the level of FVII-E25K mutant activity in the culture media was significantly lower than that of FVII wild type, whereas the antigen levels of both proteins were similar. This suggests that the E25K mutation is associated with a dysfunctional FVII molecule. In the second patient (a 47-year-old woman with FVII activity and antigen levels of less than 1% and 6% respectively), an IVS4+1 mutation and a novel -96C to T transition were detected in the double heterozygous state. In electrophoretic mobility shift assays, the -96T mutation was shown to disrupt binding of Sp1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12472587     DOI: 10.1046/j.1365-2141.2002.03933.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  2 in total

1.  Molecular characterization of 3 factor V mutations, R2174L, V1813M, and a 5-bp deletion, that cause factor V deficiency.

Authors:  Keiko Shinozawa; Kagehiro Amano; Takashi Suzuki; Asashi Tanaka; Kenji Iijima; Hoyu Takahashi; Hiroshi Inaba; Katsuyuki Fukutake
Journal:  Int J Hematol       Date:  2007-12       Impact factor: 2.490

2.  Deep learning sequence-based ab initio prediction of variant effects on expression and disease risk.

Authors:  Jian Zhou; Chandra L Theesfeld; Kevin Yao; Kathleen M Chen; Aaron K Wong; Olga G Troyanskaya
Journal:  Nat Genet       Date:  2018-07-16       Impact factor: 38.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.